Meda’s acquisition of Rottapharm completed and the rights issue of SEK 2 billion is launched
Not for release, publication or distribution, directly or indirectly, in or into the United States, Canada, Australia, Japan, Hong Kong, New Zealand, South Africa or any other jurisdiction where such distribution of this press release would be subject to legal restrictions· The acquisition of the Italian specialty pharma company Rottapharm has been completed. The total purchase price amounts to SEK 21.2 billion. · As part of the financing of the acquisition, the Board of Directors has resolved to, subject to the approval by an Extraordinary General Meeting, launch a rights issue of